Week in Review | International Myeloma Foundation

ODAC vote

Week in Review

June 5

A Closer Look at the FDA ODAC Vote Recommending DARZALEX FASPRO® as Treatment for High-Risk Smoldering Myeloma

telehealth communication

Week in Review

May 29

April and May 2025: What's New in Myeloma? 

vial of blood

Week in Review

May 22

Key Points: A Study on the Global and Regional Burden of Myeloma Among Patients Aged 40 and Over

Week in Review

May 15

Q&A with Medical Student Scholar Tyra Grischke and Dr. Ben Derman: On Collaborating and Being Published in Blood Cancer Journal

Drs Joseph Mikhael and Rafat Abonour

Week in Review

May 8

The Future of Myeloma: 'A Fireside Chat' at the Boca Raton Patient & Family Seminar

Sigurdur Ygnvi Kristinsson, MD, PhD, at DeCode Genetics

Week in Review

May 1

A Deep Dive into the IMF’s iStopMM Study

Dr. Joesph Mikhael Top Takeaways Blog from Facebook Live

Week in Review

April 18

Top Takeaways from the Facebook Live Q&A with IMF Chief Medical Officer Dr. Joseph Mikhael and IMF VP of Development Sylvia Dsouza

Dr. Saad Usmani on Key Takeaways from a Facebook Live

Week in Review

April 17

Key Takeaways from the Facebook Live Q&A on ‘Ask Me Anything About Myeloma’ with Dr. Saad Usmani

Brian Novis on his typewriter

Week in Review

March 20

35 Years of Meaningful #MyelomaMilestones

doctor and patient consultation

Week in Review

February 20

5 Facts About Multiple Myeloma That People of African Descent Need to Know

mindfulness

Week in Review

January 30

Self-Care for Myeloma Patients

Medicare

Week in Review

January 23

Navigating Medicare Drug Price Negotiations: What Myeloma Patients Need to Know About Pomalyst’s Inclusion on the Negotiation List

Subscribe to Week in Review

Give Where Most Needed